Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.
about
Design and pre-clinical evaluation of a universal HIV-1 vaccineSimilar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicryT cell recognition of weak ligands: roles of signaling, receptor number, and affinityDefining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusAntagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac diseasePersistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factorsStrain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus InfectionStealth and cunning: hepatitis B and hepatitis C viruses.The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogensHLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine releaseMolecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognitionLimited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL EscapeHLA Class I Restriction as a Possible Driving Force for Chikungunya EvolutionConstraints within major histocompatibility complex class I restricted peptides: Presentation and consequences for T-cell recognitionMHC signaling during social communicationImmunology of hepatitis B virus and hepatitis C virus infectionAge-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortalityThe role of mutations in core protein of hepatitis B virus in liver fibrosisMechanisms of immune escape in viral hepatitis.Variant antigenic peptide promotes cytotoxic T lymphocyte adhesion to target cells without cytotoxicityFrequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.Evolutionary dynamics of HIV-induced subversion of the immune response.Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades.Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis.Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus.Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activityMolecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis BPeptide antagonism as a mechanism for NK cell activation.Stability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads.Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection.Use of altered peptide ligands to modulate immune responses as a possible immunotherapy for allergies.Immunological transitions in response to antigenic mutation during viral infection.Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.Cross-reactivity in T-cell antigen recognition.Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis.
P2860
Q21092234-8BDE20AC-CA6D-4B0D-A241-CD9D4A874912Q24563454-345835C0-99A6-4AB2-90EC-EA763AFC6289Q24626152-6D37D9F4-6110-4572-ACEA-3F2262A39DE2Q24645078-44A50F2A-FDB0-4D3F-95A4-CCCC1B747596Q24680221-8518691B-C2AE-47F0-8A61-F12E499D6EA0Q27302970-3CAB1F1A-1690-4187-8FE0-3C531DB227D9Q27469607-367F47E5-AFB7-498E-B1DD-53F67B7BFCD1Q27470232-F43E170D-2510-4FED-8AAD-216407706280Q27473404-4EE3402E-E38A-4CB5-A0A6-3A391319931EQ27478341-100C6547-DE51-4EB1-9A49-D8EE64C5D207Q27485138-F8D325F7-3E34-4226-BC4D-D8FF575E7C4CQ27485186-B00E661B-8DC7-452E-95A2-A1F80960F167Q27490985-5CA4C4F2-7345-4C49-81CE-7CB95F851411Q27660158-B09BC137-CDEF-40EA-B434-D14E550EACAFQ28834594-033AD6DD-F6BE-47C0-8372-A3627753181DQ29618957-33FF9A47-3DC9-4166-AE3B-11BB507AA334Q30352787-F9248005-DD39-47BD-8BD5-C26FAF0B50A4Q33567791-5A175556-8E71-41DC-AA42-211EA572AB64Q33594871-932DB90F-B7B1-4714-A36A-8E036140811EQ33598551-6C007153-A23F-4004-A0CF-8B662555E567Q33647187-08AD2C60-C673-478C-A2D5-48193FB7DC4FQ33650076-D6A5FB66-AA32-4028-A4E4-60AB4C2B5674Q33683341-93E219B3-FE04-4AD4-A4F7-01312BF3A6FAQ33782497-F36EA0E2-8C52-4274-B5F9-1744AAC57DAAQ33783694-F7A07C9B-7D1A-432B-8E12-61B19F0E47B0Q33785674-6EB33ABB-2141-4620-894B-E181714ACAD7Q33808561-BE672232-D179-4413-B8FD-FA7CAFE4E2F5Q33812154-220A2D8C-7F52-4C0B-BDE9-A1BE6C156EF3Q33850918-185DA6CB-D00D-429A-85C8-A2F3BC9A00E1Q33866045-E0A03964-272A-461F-A2D7-15BC1AD9B64FQ33867720-1B4F2403-8D7F-4315-8752-4BCE3FB651DDQ33883607-95028C01-5B1A-49F5-8089-F56FD412476FQ33933479-0998C4C7-6FBF-447F-8070-57697589F334Q33934932-FC16D96C-2556-430D-A37B-0BAB988624E5Q33939747-17A68ABB-9187-42C3-8B85-DD26A59F5C92Q33987217-C20BFD2C-92AE-44B1-9A51-14B9ED32CC15Q34047035-593F5320-F03A-46C4-AA49-F63113946B0BQ34069815-D2DCCF08-3464-4F68-91A6-C85BEEAE45A3Q34249351-7BDA7809-5C38-4689-8194-846E67EC833BQ34307160-B22C0D8E-CAB9-4902-8108-64FFA5202313
P2860
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Natural variants of cytotoxic ...... r antiviral cytotoxic T cells.
@en
type
label
Natural variants of cytotoxic ...... r antiviral cytotoxic T cells.
@en
prefLabel
Natural variants of cytotoxic ...... r antiviral cytotoxic T cells.
@en
P2093
P356
P1433
P1476
Natural variants of cytotoxic ...... r antiviral cytotoxic T cells.
@en
P2093
Bertoletti A
Chisari FV
De Carli M
Fiaccadori F
P2888
P304
P356
10.1038/369407A0
P407
P577
1994-06-01T00:00:00Z
P6179
1023251675